Financial Ratios

BALAXI PHARMACEUTICALS LTD.

NSE : BALAXIBSE : ISIN CODE : INE618N01014Industry : TradingHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE585.009.65 (+1.68 %)
PREV CLOSE( ) 575.35
OPEN PRICE ( ) 574.95
BID PRICE (QTY) 585.00 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3584
TODAY'S LOW / HIGH( ) 574.75 596.00
52 WK LOW / HIGH ( )399.95 686.3
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)15.9314.6715.136.506.47
   CEPS(Rs)16.4414.9215.226.506.48
   DPS(Rs)0.000.500.000.000.00
   Book NAV/Share(Rs)80.3557.9143.2528.1111.58
   Tax Rate(%)27.7425.5426.5329.2919.41
Margin Ratios
   Core EBITDA Margin(%)15.6017.0821.9018.9511.46
   EBIT Margin(%)21.2319.5423.8820.2317.96
   Pre Tax Margin(%)20.7619.4523.7120.1317.94
   PAT Margin (%)15.0014.4817.4214.2314.46
   Cash Profit Margin (%)15.4814.7317.5214.2514.49
Performance Ratios
   ROA(%)15.3319.4528.3329.5250.44
   ROE(%)23.2229.0042.4241.0777.47
   ROCE(%)28.2237.1455.4258.3896.22
   Asset Turnover(x)1.021.341.632.073.49
   Sales/Fixed Asset(x)19.1661.00179.45461.171311.03
   Working Capital/Sales(x)1.683.363.781.704.26
Efficiency Ratios
   Fixed Capital/Sales(x)0.050.020.010.000.00
   Receivable days220.07180.60166.70146.76146.96
   Inventory Days5.050.001.786.660.00
   Payable days73.3776.8567.8950.0038.77
Valuation Parameters
   PER(x)33.2923.9734.6611.395.88
   PCE(x)32.2623.5734.4611.385.87
   Price/Book(x)6.606.0712.132.633.28
   Yield(%)0.000.140.000.000.00
   EV/Net Sales(x)4.933.486.071.540.84
   EV/Core EBITDA(x)22.7017.5925.327.624.67
   EV/EBIT(x)23.2117.8225.437.634.68
   EV/CE(x)5.185.8911.282.513.24
   M Cap / Sales4.993.476.041.620.85
Growth Ratio
   Net Sales Growth(%)6.7616.6090.37235.65
   Core EBITDA Growth(%)17.09-3.77125.44277.92418.41
   EBIT Growth(%)15.97-4.57124.68278.15417.14
   PAT Growth(%)10.60-3.08132.98230.41355.35
   EPS Growth(%)8.63-3.08132.980.45355.35
Financial Stability Ratios
   Total Debt/Equity(x)0.130.030.080.000.00
   Current Ratio(x)2.842.261.903.752.23
   Quick Ratio(x)2.802.261.903.662.23
   Interest Cover(x)45.29203.45140.54196.861061.57
   Total Debt/Mcap(x)0.020.010.010.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.